Watton Corey Michael sold $138K of ZVRA
Watton Corey Michael sold 12,300 shares of ZEVRA THERAPEUTICS, INC. (ZVRA) at $11.25 ($0.14M total) on 2026-08-10.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the director’s open-market sale of 12,300 shares at $11.2502 on 2026-08-10, with no pre-arranged 10b5-1 plan stated.
Market read
Traders may briefly reassess sentiment around insider behavior, but there is no new operational or financial catalyst in the text.
What to watch
The filing shows holdings after sale (1,800 shares) but provides no context on total compensation, prior sale cadence, or whether other insiders also sold around the same time.
Background
The article is an SEC Form 4 insider transaction disclosure for ZEVRA THERAPEUTICS, INC.
Ticker impact
Zevra Therapeutics director Watton Corey Michael sold 12,300 shares in an open-market transaction for about $138,377 on 2026-08-10.
Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless paired with other disclosures.
Form 4 insider sales are common and often non-informational; the filing provides transaction details but no accompanying guidance, results, or operational change.
Market effects
No clear sector read-through from a single director open-market sale.
None indicated.
None indicated.
Counterpoint
The absence of a 10b5-1 plan does not necessarily imply negative information; sales can be driven by diversification, taxes, or pre-existing personal liquidity needs.
Key entities
- issuerZevra Therapeutics, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderWatton Corey Michael
Director who sold 12,300 shares in an open-market sale.
